DLA Piper advises MVision AI on funding round

DLA Piper has advised Finnish software company MVision AI on their EUR 5.4 million funding round that was led by J12 Ventures and Voima Ventures.
 
MVision AI, founded in 2017, is a pioneering, cloud-based software service provider for radiotherapy treatment planning. MVision AI uses artificial intelligence to automate cancer treatment with an AI-powered automatic segmentation tool. MVision AI’s technology has been used to treat more than 100,000 cancer patients in 14 countries, with most patients originating in Finland, Sweden and the UK.
 
“Working with DLA Piper was smooth. Jonathan had been involved also in previous funding rounds and already knew the company well. The service was provided with great expertise and flexibility and our questions got answered on short notice if needed.” says Anu Savola, CFO of MVision AI.
 
The DLA Piper advisory team comprised Jonathan Andersin and Eliel Ahmala.